Skip to content
Skip over generic navigation
Skip over primary navigation
Skip over visual
Skip over functional column
Our injectable depots play to API strengths and widen treatment horizons.
Decades of continuously pushing the technology envelope – from contraceptive steroids in the 1970s to pioneering work with LHRH peptides in the 1980s and microencapsulation experiments with antibiotics aboard space shuttle flights – give Pharma Polymers & Services an unrivalled body of knowledge in microparticle and nanoparticle-scale drug delivery - in virtually all drug classes.
Evonik’s proprietary FormEZE™ delivery technology, for instance, can deliver drug solids via a 27-G needle for enhanced bioavailability and greater patient comfort, including easier self-administration.
Bioresorbable implants - launchpads into a new dimension of efficacy and patient comfort.
Evonik’s implant technology works with biodegradable as well as non-biodegradable polymers, providing you with a drug delivery platform that offers more possibilities for fine-tuning drug release and degradation profiles. Precise process and surface property calibration means our implants can deliver larger API quantities over longer periods with a smaller footprint. We can formulate most drug classes into implants, too – particularly small molecules and peptides that are not temperature sensitive.
More routes of administration.
The range and flexibility of our delivery systems enables API developers to explore new routing alternatives. The advantages are: